Literature DB >> 8648743

Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

M C Estable1, B Bell, A Merzouki, J S Montaner, M V O'Shaughnessy, I J Sadowski.   

Abstract

Despite extensive in vitro studies identifying a myriad of cellular transcription factors that bind the human immunodeficiency virus type 1 5' long terminal repeat (LTR), the relative contribution of these factors to human immunodeficiency virus type 1 replication in infected individuals remains obscure. To address this question, we investigated 478 proviral quasispecies derived from uncultured peripheral blood mononuclear cells of 42 patients representing all stages of infection. In addition to highly conserved TATA box, SP-1, and NF-kappaB sites, the Ets core and an adjacent 5'-ACYGCTGA-3' motif were extremely conserved. Importantly, the most frequent naturally occurring length polymorphism (MFNLP) duplicated 5'-ACYGCTGA-3' motifs in LTRs in which this same motif was disrupted or in LTRs in which a single point mutation to the Ets core ablated binding of c-Ets 1 and another factor distinct from both c-Ets 1 and Elf 1. The MFNLP's location was precise (position -121) and surprisingly frequent (38% of patients) and demarcated LTR Nef-coding sequences from LTR noncoding sequences that appear to be evolving independently. Aside from these features, we found no definitive clinical or transcription phenotype common to all MFNLP LTRs. We also found previously described and novel point polymorphisms, including some conferring TAR-dependent and TAR- independent Tat unresponsiveness, and showed that differential binding of nuclear factor(s) to a TCTAA TATA box variant may be the mechanism for the latter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648743      PMCID: PMC190286     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Target Detection Assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein.

Authors:  H J Thiesen; C Bach
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

2.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

3.  Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro.

Authors:  C R Wobbe; K Struhl
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

Authors:  L A Feig; G M Cooper
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.

Authors:  S Roy; U Delling; C H Chen; C A Rosen; N Sonenberg
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

6.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

7.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

8.  Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient.

Authors:  M Ait-Khaled; J E McLaughlin; M A Johnson; V C Emery
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

9.  Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.

Authors:  E I Golub; G G Li; D J Volsky
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Authors:  J A Garcia; F K Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  35 in total

1.  HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.

Authors:  H L Ross; S Gartner; J C McArthur; J R Corboy; J J McAllister; S Millhouse; B Wigdahl
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

2.  Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Authors:  Yujie Liu; Michael R Nonnemacher; Devin L Stauff; Luna Li; Anupam Banerjee; Bryan Irish; Evelyn Kilareski; Nirmala Rajagopalan; Joyce B Suchitra; Zafar K Khan; Udaykumar Ranga; Brian Wigdahl
Journal:  Biomed Pharmacother       Date:  2010-09-25       Impact factor: 6.529

3.  Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.

Authors:  Hung-Chih Yang; Lin Shen; Robert F Siliciano; Joel L Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-31       Impact factor: 11.205

4.  Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter.

Authors:  Matthew S Dahabieh; Marcel Ooms; Tom Malcolm; Viviana Simon; Ivan Sadowski
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

5.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Authors:  Masahide Horiba; Lindsey B Martinez; James L Buescher; Shinji Sato; Jenae Limoges; Yunquan Jiang; Clinton Jones; Tsuneya Ikezu
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

Review 6.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

7.  Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF.

Authors:  Jiguo Chen; Tom Malcolm; Mario C Estable; Robert G Roeder; Ivan Sadowski
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.

Authors:  Aaron C Logan; Dennis L Haas; Tal Kafri; Donald B Kohn
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  E box motifs as mediators of proviral latency of human retroviruses.

Authors:  Jean-Michel Terme; Sébastien Calvignac; Madeleine Duc Dodon; Louis Gazzolo; Albert Jordan
Journal:  Retrovirology       Date:  2009-09-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.